XML 45 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Collaboration agreements - GlaxoSmithKline (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2022
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Aug. 06, 2022
performanceObligation
Collaboration agreements                
Collaboration revenue   $ 12,598 $ 7,698 $ 24,136 $ 26,154      
Deferred revenue   115,237 133,096 115,237 133,096 $ 125,314 $ 147,653  
GSK Agreement                
Collaboration agreements                
Upfront payment received $ 100,000              
Collaboration arrangement, potential option exercise receivable $ 90,000              
Performance obligations identified | performanceObligation               2
Collaboration revenue   500 $ 500 600 $ 1,800      
Deferred revenue   $ 94,000   $ 94,000   $ 94,600